BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1813207)

  • 1. Impact of tumour marker measurements upon management of patients with carcinoma of the ovary.
    Rustin GJ
    Dis Markers; 1991; 9(3-4):153-8. PubMed ID: 1813207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serological monitoring of epithelial ovarian cancer.
    Fisken J; Leonard RC; Badley A; Jönrup I; Aspinall L; Sturgeon C; Roulston JE
    Dis Markers; 1991; 9(3-4):175-90. PubMed ID: 1813209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical applications of CA 125 carcinoma of the ovary].
    Tomioka E; Fujita MM; Izaki M; Lin WF; Moriyama AJ; Bastos Ada C
    Rev Paul Med; 1991; 109(3):123-30. PubMed ID: 1947608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Application of monoclonal antibody OC 125 in gynecological oncology].
    Wu AR; Wang EY; Wang XX; Jia XH; Li L
    Zhonghua Zhong Liu Za Zhi; 1988 Mar; 10(2):132-6. PubMed ID: 3208653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Results of CA-125 tumor marker determination in patients with ovarian carcinoma].
    Miladinović D; Paunović R; Paunković N
    Jugosl Ginekol Perinatol; 1989; 29(3-4):83-5. PubMed ID: 2601371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating tumour markers in ovarian tumours.
    von Schlippe M; Rustin GJ
    Forum (Genova); 2000; 10(4):383-92. PubMed ID: 11535987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative study of mucin-like carcinoma-associated antigen (MCA), CA 125, CA 19-9 and CEA in patients with ovarian cancer.
    Koelbl H; Schieder K; Neunteufel W; Bieglmayer C
    Neoplasma; 1989; 36(4):473-8. PubMed ID: 2770933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The value of CA 125 determination in the serum of patients with ovarian cancer].
    Bartel U; Johannsen B; Elling D
    Zentralbl Gynakol; 1989; 111(5):301-9. PubMed ID: 2728673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CA 125 in ovarian cancer.
    van der Burg ME; Lammes FB; Verweij J
    Neth J Med; 1992 Feb; 40(1-2):36-51. PubMed ID: 1579185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The CA-125 tumor marker in epithelial ovarian cancers of stage I].
    Nagele F; Vavra N; Kurz C; Sevelda P
    Wien Klin Wochenschr; 1993; 105(20):585-8. PubMed ID: 8259686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ovarian malignancy.
    Niloff JM
    Curr Opin Obstet Gynecol; 1991 Feb; 3(1):66-72. PubMed ID: 1878499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The role of tumor marker CA 125 in the treatment of ovarian cancer].
    Porsbjerg CM; Sørensen JB; Lund BA
    Ugeskr Laeger; 1998 Feb; 160(7):995-1000. PubMed ID: 9477746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of the CA 125 assay in the management of ovarian cancer.
    Niloff JM
    Oncology (Williston Park); 1988 Aug; 2(8):67-76. PubMed ID: 3275060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical experience with CA-50 in the serum of carcinoma patients.
    Habib NA; Hershman MJ; Kelly SB; Taylor G; Williamson RC; Wood CB
    Eur J Surg Oncol; 1989 Aug; 15(4):361-6. PubMed ID: 2759254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ovarian carcinoma antigen (CA 125) and ovarian cancer (clinical follow-up and prognostic studies)].
    Göcze P; Vahrson H
    Orv Hetil; 1993 Apr; 134(17):915-8. PubMed ID: 8479736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A CA 12-5 prognostic score for epithelial ovarian cancers].
    Klein M; Rosen A; Sevelda P; Spona J; Beck A
    Gynakol Rundsch; 1990; 30 Suppl 1():70-2. PubMed ID: 2079305
    [No Abstract]   [Full Text] [Related]  

  • 17. [Value of biological markers in the diagnosis and monitoring of cystadenocarcinoma].
    Bidart JM; Bellet D
    Rev Prat; 1989 Nov; 39(26):2317-20. PubMed ID: 2595221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ca 125 in the diagnosis and follow-up of ovarian neoplasia].
    Baviera G; Antico F; Bagnato A; Purello D'Ambrosio F
    Riv Eur Sci Med Farmacol; 1989 Feb; 11(1):59-64. PubMed ID: 2798993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of monoclonal antibody-defined tumor markers in four carcinomas.
    Wu JT
    Ann Clin Lab Sci; 1989; 19(1):17-26. PubMed ID: 2916833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum tumor markers.
    Perkins GL; Slater ED; Sanders GK; Prichard JG
    Am Fam Physician; 2003 Sep; 68(6):1075-82. PubMed ID: 14524394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.